HeartsciencesHSCS
13F holders, Q3 2024 (September 30)6holders −1
1new positions
2sold out
$4.75avg. 13F price*
At the end of Q3 2024, 6 institutions reported holding Heartsciences Inc. (HSCS) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were HRT Financial LP ($48K), Tower Research Capital LLC (TRC) ($9K) and UBS Group AG ($3K).
- Company
- Heartsciences Inc.
- Filed as
- HEART TEST LABORATORIES INC (Q3 2024)
- CUSIP
- 42254E302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $48K |
| Exits | 2 | $15K |
All 13F filers, Q2 2024 → Q3 2024: 11,470 shares bought and 8,685 shares sold, net +2,785 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| HRT Financial LP | 0.00% | New | 10,166 | $48K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +225.9% | 1,877 | $9K |
| UBS Group AG | 0.00% | Reduce -89.3% | 681 | $3K |
| Oliver Lagore Vanvalin Investment Group | 0.00% | Reduce -37.1% | 305 | $1K |
| Bank of America Corp. | 0.00% | Add +75.0% | 7 | $34 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is HSCS's weight in each manager's 13F, not the share of Heartsciences Inc. the manager owns.